Track the ディーブイエックス株式会社 stock price and the full management transaction log of the company, a listed issuer based in Japan. Shares trade on JP JP, under the supervision of EDINET (Japan FSA). Operating in the Health Care sector, ディーブイエックス株式会社 has recorded 20 insider filings. Market capitalisation: €9.9bn. The latest transaction was reported on 24 March 2026 (Holding update). Among the most active insiders: Hikari Tsushin K.K.. Every trade is free.
20
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,648 of 28,064 companies
41.1
score / 100
Value
40
Quality
42
FCF yld-18%
Earn yld2.3%
EV/EBITDA9.3x
ROE2.5%
Gross mgn9.6%
Net mgn0.4%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
DVX Corporation is a company listed on the XTKS market, specializing in the health and pharmaceutical sector. It focuses on the development and commercialization of innovative pharmaceutical products.